Our News on Newswise

Updated Report on Trends in Global PD-1/PD-L1 Immunotherapy Clinical Development from the Cancer Research Institute Published in Nature Reviews Drug Discovery

Latest analysis of the global PD-1/PD-L1 immunotherapy clinical development pipeline reveals dramatic growth over past two years in number of trials, drug combinations, and drug targets, but lower patient recruitment rates in the U.S. compared to...
4-Nov-2019 11:00 AM EST Add to Favorites

Latest Global Immuno-Oncology Landscape Report from the Cancer Research Institute Published in Nature Reviews Drug Discovery

Cancer Research Institute analysis of the global immuno-oncology landscape shows dramatic two-year growth in therapeutic targets and I-O drugs in clinical development
27-Sep-2019 5:05 AM EDT Add to Favorites

Cancer Research Institute Announces 2019 Recipients of Its Top Scientific and Philanthropic Awards Honoring Discovery, Service in Advancing Cancer Immunology and Immunotherapy Research

The Cancer Research Institute (CRI), a nonprofit organization dedicated to advancing the discovery and development of powerful immunotherapies for all forms of cancer, has announced the 2019 recipients of its highest scientific and philanthropic...
26-Sep-2019 2:00 AM EDT Add to Favorites

Newswise: Chordoma_Foundation_logo.png

Cancer Research Institute and Chordoma Foundation Partner to Advance Immunotherapy Research in Rare Cancer

Two nonprofits team up to fund research aimed at discovering and developing immunotherapeutic approaches to treating chordoma, a rare type of bone cancer.
28-Jun-2019 10:00 AM EDT Add to Favorites

Cancer Research Institute Hosts Inaugural “Immuno-Oncology: A Future Look” Media and Investor Event in New York City

The Cancer Research Institute (CRI) will host its inaugural “Immuno-Oncology: A Future Look” event for healthcare investment analysts and media today in New York City at the New York Academy of Sciences from 10:00 am – 12:00 pm ET.
21-Jun-2019 10:00 AM EDT Add to Favorites

Cancer Research Institute Names New Stars of Cancer Immunotherapy Research

Five U.S. scientists have been awarded $1.25 million each from the Cancer Research Institute to carry out high-risk, high-reward cancer immunology research with potential to transform cancer treatment
21-Jun-2019 10:00 AM EDT Add to Favorites

Cancer Research Institute Champions Cancer Immunotherapy Month™ in June

The Cancer Research Institute announced today a series of public education and awareness offerings during its seventh annual Cancer Immunotherapy Month™ in June.
21-May-2019 3:00 PM EDT Add to Favorites

New Report Charts Dramatic Growth in the Global Clinical Trial Landscape for PD-1/L1 Immune Checkpoint Inhibitors

Latest Cancer Research Institute update on the landscape of anti-PD1/L1 checkpoint inhibitor clinical trials
28-Nov-2018 9:00 AM EST Add to Favorites


See All News

Our Experts on Newswise

Expert Available for Commentary on Recent FDA Analysis of TNF Blockers

The FDA announced on Aug 4 2009 that tumor necrosis factor (TNF) blockers used in the treatment of immune disorders carry an increased risk of lymphoma and other cancers in children and adolescents. The discoverer of TNF-alpha, Lloyd J. Old, M.D., a...
7-Aug-2009 9:00 AM EDT

PROVENGE Cancer Vaccine Heralds New Dawn in Cancer Therapy

Dendreon's PROVENGE for the treatment of advanced prostate cancer is the first active cellular immunotherapy to prolong patient survival, according to data from a pivotal phase III clinical trial announced at yesterday's AUA annual meeting in...
29-Apr-2009 11:20 AM EDT

See All Experts

Our YouTube Videos

About

The mission of the Cancer Research Institute is to extend the lives of cancer patients and reduce cancer-related deaths by fueling the development of a news class of smarter, more effective treatments that mobilize our body's natural natural immune defenses against all types of cancer.

Contacts

Brian Brewer
Marketing & Communications Director

bbrewer@cancerresearch.org

212-688-7515

Elliot Fox

efox@w20group.com

Twitter

close
0.27087